Emergent BioSolutions CEO Robert Kramer's 2019 pay jumps 54% to $3.7M
Emergent BioSolutions reports 2019 executive compensation
By ExecPay News
Published: April 9, 2020
Emergent BioSolutions reported fiscal year 2019 executive compensation information on April 9, 2020.
In 2019, seven executives at Emergent BioSolutions received on average a compensation package of $2.4M, a 1% decrease compared to previous year.
Average pay of disclosed executives at Emergent BioSolutions
Robert G. Kramer, Chief Executive Officer, received $3.7M in total, which increased by 54% compared to 2018. 39% of Kramer's compensation, or $1.4M, was in stock awards. Kramer also received $557K in non-equity incentive plan, $1M in option awards, $678K in salary, as well as $5.7K in other compensation.
Robert Kramer, Chief Executive Officer, received a compensation package of $3.7M, which increased by 54% compared to previous year. 39% of the compensation package, or $1.4M, was in stock awards.
Fuad El-Hibri, Chairman, earned $3M in 2019, a 1% increase compared to previous year.
Richard S. Lindahl, Chief Financial Officer, received $1.9M in 2019, which increases by 16% compared to 2018.
Atul Saran, General Counsel, earned $1.9M in 2019, a 10% increase compared to previous year.
Adam Havey, Executive Vice President, Business Operations, received $1.8M in 2019, which increases by 11% compared to 2018.
Daniel J. Abdun-Nabi, Chief Executive Officer, earned $633K in 2019, a 85% decrease compared to previous year.
Related executives
Fuad El-Hibri
Emergent BioSolutions
Chairman
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
Adam Havey
Emergent BioSolutions
Chief Operating Officer
Atul Saran
Emergent BioSolutions
Executive Vice Presidentand Chief Strategy andand Development Officer
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
You may also like
Source: SEC filing on April 9, 2020.